Revenue
2022
2023
2024
2025
Picard Medical, Inc. (PMI)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $4.9M | $4.4M | $5.0M | $4.1M |
| Gross profit | −$204,000 | −$112,000 | −$2.3M | −$5.0M |
| Gross margin | −4.13% | −2.55% | −45.83% | −121.27% |
| Research & development | $3.0M | $3.4M | $2.2M | $1.9M |
| Operating expenses | $13.1M | $13.6M | $13.2M | $6.1M |
| Operating income | −$13.3M | −$13.7M | −$15.5M | −$11.1M |
| Operating margin | −268.36% | −312.28% | −307.40% | −269.07% |
| EBITDA | −$13.1M | −$13.5M | −$14.8M | −$10.6M |
| EBITDA margin | −265.06% | −307.13% | −294.39% | −257.89% |
| Net income | −$27.0M | −$21.1M | −$15.6M | −$11.2M |
| Net profit margin | −546.60% | −479.50% | −308.72% | −271.53% |
| Basic EPSper basic share | -$37.50 | -$149.50 | -$12.49 | -$8.79 |
| Diluted EPSper diluted share | -$37.50 | -$16.47 | -$12.49 | -$8.79 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Versa Capital Group, LLC / Sindex SSI Lending, LLC / VERSA CAPITAL FUND III, L.P. / Versa UGP-III, LLC / Versa FGP-III, L.P. / Segall Gregory L | 7.94M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data